Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 10: 559-562, 1964;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, D.

Clinical Chemistry, Vol 10, 559-562, Copyright © 1964 by the American Association for Clinical Chemistry

Limitations in Clinical Use of a Screening Test for Protein

Derek Watson 1

1 Division of Biochemistry, The Royal Women's Hospital, Carlton N.3, Victoria, Australia.

Quantitative estimation of protein in cerebrospinal fluid, amniotic, and similar protein-poor body fluids by means of a widely used strip test is not reliable. For this purpose, the turbidity test of Meulemans (1960) appears satisfactory. The strip test is a convenient and reliable means of detecting protein (albumin-globulin mixtures) in the urine of pregnant women.

Submitted on December 11, 1962






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1964 by the American Association for Clinical Chemistry.